Updated on 2026/03/11

写真a

 
YAMAGUCHI Shukuro
 
Organization
Nagoya University Hospital Cardiology Assistant Professor of Hospital
Title
Assistant Professor of Hospital

Degree 1

  1. 博士(医学) ( 2020.11   名古屋大学 ) 

Research Areas 1

  1. Life Science / Cardiology

Current Research Project and SDGs 2

  1. 重症虚血肢に対する脂肪組織由来再生(幹)細胞を用いた血管新生療法

  2. 心血管疾患における核酸医薬の開発

Research History 4

  1. Nagoya University   Nagoya University Hospital Cardiology   Assistant Professor of Hospital

    2025.1

  2. Nagoya University   Designated Assistant Professor

    2024.9 - 2024.12

  3. Cedars-Sinai Medical Center   Smidt Heart Institute   研究員

    2021.4 - 2024.8

  4. Nagoya University   Assistant Professor of Hospital

    2020.4 - 2021.3

Professional Memberships 2

  1. 日本循環器学会

    2013.4

  2. 日本内科学会

    2013.4

 

Papers 17

  1. Therapeutic Lymphangiogenesis Using Induced Cardiac Fibroblasts Protects the Heart From Heart Failure With Preserved Ejection Fraction Progression by Exerting Anti-Inflammatory and Antifibrotic Effects.

    Luo H, Shimizu Y, Iwamiya T, Matsuoka Y, Chen X, Liu T, Che Y, Hayashi T, Pu Z, Yamaguchi S, Sakamoto K, Murohara T

    Circulation journal : official journal of the Japanese Circulation Society     2026.1

     More details

    Language:English  

    DOI: 10.1253/circj.CJ-25-0757

    PubMed

  2. Augmentation of DNA exonuclease TREX1 in macrophages as a therapy for cardiac ischemic injury.

    Ibrahim AG, Ciullo A, Komuro H, Miyamoto K, Jones XM, Yamaguchi S, Tsi K, Anderson J, Godoy Coto J, Kitka D, Liao K, Li C, Rannou A, Nawaz A, Morris A, Marbán CH, Lee J, Manriquez N, Hong Y, Naveen Kumar A, Dawkins JF, Rogers RG, Marbán E

    Science translational medicine   Vol. 17 ( 827 ) page: eadp1338   2025.12

     More details

    Language:English  

    DOI: 10.1126/scitranslmed.adp1338

    PubMed

  3. Oral Bioavailability of a Noncoding RNA Drug, TY1, That Acts on Macrophages. Open Access

    Yamaguchi S, Miyamoto K, Jones XM, Ciullo A, Tsi K, Anderson J, Komuro H, Soussi S, Morris A, Kitka D, Liu DZ, Nguyen A, Marbán E, Ibrahim AGE

    Journal of extracellular biology   Vol. 4 ( 8 ) page: e70081   2025.8

     More details

  4. Myonectin stimulates endothelial angiogenic activity in vitro and in vivo.

    Masutomi T, Ouchi N, Yamaguchi S, Ohashi K, Otaka N, Pu Z, Shimizu Y, Murohara T, Shibata R

    Nagoya journal of medical science   Vol. 87 ( 2 ) page: 285 - 294   2025.5

     More details

    Language:English  

    DOI: 10.18999/nagjms.87.2.285

    PubMed

  5. Intravenous and oral administration of the synthetic RNA drug, TY1, reverses heart failure with preserved ejection fraction in mice.

    Miyamoto K, Jones XM, Yamaguchi S, Ciullo A, Li C, Coto JG, Tsi K, Anderson J, Morris A, Marbán E, Ibrahim AG

    Basic research in cardiology   Vol. 120 ( 2 ) page: 363 - 371   2025.4

     More details

    Language:English  

    DOI: 10.1007/s00395-024-01095-5

    PubMed

  6. A novel micropeptide, Slitharin, exerts cardioprotective effects in myocardial infarction.

    Ibrahim AGE, Ciullo A, Yamaguchi S, Li C, Antes T, Jones X, Li L, Murali R, Maslennikov I, Sundararaman N, Soetkamp D, Cingolani E, Van Eyk J, Marbán E

    Proteomics. Clinical applications   Vol. 18 ( 5 ) page: e2300128   2024.9

     More details

    Language:English  

    DOI: 10.1002/prca.202300128

    PubMed

  7. Omentin Modulates Chronic Cardiac Remodeling After Myocardial Infarction. Open Access

    Ito M, Shibata R, Ohashi K, Otaka N, Yamaguchi S, Ogawa H, Enomoto T, Masutomi T, Murohara T, Ouchi N

    Circulation reports   Vol. 5 ( 2 ) page: 46 - 54   2023.2

     More details

  8. TDO2-augmented fibroblasts secrete EVs enriched in immunomodulatory Y-derived small RNA. Open Access

    Ciullo A, Peck K, Jones X, Yamaguchi S, Morris AA, Kumar AN, Li L, Lee J, Dos Santos RM, Cingolani E, Ibrahim AG

    Journal of extracellular biology   Vol. 2 ( 2 ) page: e73   2023.2

     More details

    Language:English  

    DOI: 10.1002/jex2.73

    Open Access

    PubMed

  9. Adipose-derived regenerative cells as a promising therapy for cardiovascular diseases: an overview. Open Access

    Yamaguchi S, Shimizu Y, Murohara T, Shibata R

    Nagoya journal of medical science   Vol. 84 ( 2 ) page: 208 - 215   2022.5

     More details

  10. Zinc deficiency impairs ischemia-induced angiogenesis. Open Access

    Tsuruoka T, Kodama A, Yamaguchi S, Masutomi T, Koyama A, Murohara T, Komori K, Shibata R

    JVS-vascular science   Vol. 3   page: 30 - 40   2022

     More details

  11. Adverse Effect of Circadian Rhythm Disorder on Reparative Angiogenesis in Hind Limb Ischemia. Open Access

    Tsuzuki K, Shimizu Y, Suzuki J, Pu Z, Yamaguchi S, Fujikawa Y, Kato K, Ohashi K, Takefuji M, Bando YK, Ouchi N, Calvert JW, Shibata R, Murohara T

    Journal of the American Heart Association   Vol. 10 ( 16 ) page: e020896   2021.8

     More details

  12. No influence on tumor growth by intramuscular injection of adipose-derived regenerative cells: safety evaluation of therapeutic angiogenesis with cell therapy.

    Suzuki J, Shimizu Y, Tsuzuki K, Pu Z, Narita S, Yamaguchi S, Katagiri T, Iwata E, Masutomi T, Fujikawa Y, Shibata R, Murohara T

    American journal of physiology. Heart and circulatory physiology   Vol. 320 ( 1 ) page: H447 - H457   2021.1

     More details

    Language:English   Publisher:American Journal of Physiology - Heart and Circulatory Physiology  

    DOI: 10.1152/ajpheart.00564.2020

    Web of Science

    Scopus

    PubMed

  13. Therapeutic angiogenesis using autologous adipose-derived regenerative cells in patients with critical limb ischaemia in Japan: a clinical pilot study. Open Access

    Katagiri T, Kondo K, Shibata R, Hayashida R, Shintani S, Yamaguchi S, Shimizu Y, Unno K, Kikuchi R, Kodama A, Takanari K, Kamei Y, Komori K, Murohara T

    Scientific reports   Vol. 10 ( 1 ) page: 16045   2020.9

     More details

    Language:English   Publisher:Scientific Reports  

    DOI: 10.1038/s41598-020-73096-y

    Open Access

    Web of Science

    Scopus

    PubMed

  14. Therapeutic Angiogenesis Using Bone Marrow Mononuclear Cell Transplantation - A New Standard Treatment for Thromboangiitis Obliterans? Open Access

    Shibata R, Yamaguchi S, Murohara T

    Circulation journal : official journal of the Japanese Circulation Society   Vol. 84 ( 4 ) page: 549 - 550   2020.3

     More details

    Language:English   Publisher:Circulation Journal  

    DOI: 10.1253/circj.CJ-20-0137

    Open Access

    Web of Science

    Scopus

    PubMed

    CiNii Research

  15. Adipolin/CTRP12 protects against pathological vascular remodelling through suppression of smooth muscle cell growth and macrophage inflammatory response.

    Ogawa H, Ohashi K, Ito M, Shibata R, Kanemura N, Yuasa D, Kambara T, Matsuo K, Hayakawa S, Hiramatsu-Ito M, Otaka N, Kawanishi H, Yamaguchi S, Enomoto T, Abe T, Kaneko M, Takefuji M, Murohara T, Ouchi N

    Cardiovascular research   Vol. 116 ( 1 ) page: 237 - 249   2020.1

     More details

    Language:English   Publisher:Cardiovascular Research  

    DOI: 10.1093/cvr/cvz074

    Web of Science

    Scopus

    PubMed

  16. C1q/TNF-Related Protein 9 Promotes Revascularization in Response to Ischemia via an eNOS-Dependent Manner. Open Access

    Yamaguchi S, Shibata R, Ohashi K, Enomoto T, Ogawa H, Otaka N, Hiramatsu-Ito M, Masutomi T, Kawanishi H, Murohara T, Ouchi N

    Frontiers in pharmacology   Vol. 11   page: 1313   2020

     More details

    Language:English   Publisher:Frontiers in Pharmacology  

    DOI: 10.3389/fphar.2020.01313

    Open Access

    Web of Science

    Scopus

    PubMed

  17. Eed/Sox2 regulatory loop controls ES cell self-renewal through histone methylation and acetylation. Open Access

    Ura H, Murakami K, Akagi T, Kinoshita K, Yamaguchi S, Masui S, Niwa H, Koide H, Yokota T

    The EMBO journal   Vol. 30 ( 11 ) page: 2190 - 204   2011.6

     More details

    Language:English  

    DOI: 10.1038/emboj.2011.126

    PubMed

▼display all